Cargando…
Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition
Aberrant expression of the phosphatidylinositol 3-kinase (PI3K) signalling pathway is often associated with tumourigenesis, progression and poor prognosis. Hence, PI3K inhibitors have attracted significant interest for the treatment of cancer. In this study, a series of new 6-(imidazo[1,2-a]pyridin-...
Autores principales: | Li, Mei, Wang, Daoping, Li, Qing, Luo, Fang, Zhong, Ting, Wu, Hongshan, Xiong, Liang, Yuan, Meitao, Su, Mingzhi, Fan, Yanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095550/ https://www.ncbi.nlm.nih.gov/pubmed/37047827 http://dx.doi.org/10.3390/ijms24076851 |
Ejemplares similares
-
5-(4-Methylphenyl)-2,3-diphenyl-5,6-dihydroimidazo[1,2-c]quinazoline
por: Zhang, Jiankang, et al.
Publicado: (2010) -
2-Methyl-6-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carbonitrile
por: Fun, Hoong-Kun, et al.
Publicado: (2011) -
6-Bromoimidazo[1,2-a]pyridin-8-amine
por: Dahmani, Siham, et al.
Publicado: (2011) -
Crystal structure of 5-(5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazolin-6-yl)-2-methoxyphenol
por: Adam, Farook, et al.
Publicado: (2015) -
2-(Ethylsulfinyl)imidazo[1,2-a]pyridine-3-sulfonamide
por: Gong, Yaling, et al.
Publicado: (2012)